Opportunity Information: Apply for CDC RFA PS14 141202CONT16
Apply for CDC RFA PS14 141202CONT16
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "World Health Organization Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Aug 19, 2015 and posted on Aug 19, 2015.
- Applicants must submit their applications by Aug 25, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under 1U52PS004640 CONT 16 Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations World Health Organization.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This opportunity is a CDC continuation cooperative agreement focused on supporting the World Health Organization's ongoing work to prevent and control tuberculosis (TB), with a particular emphasis on multidrug-resistant TB (MDR-TB) and TB affecting vulnerable populations. It is not a new, open competition. Instead, it was issued to continue funding for an existing, previously funded effort, indicating the government intended to maintain momentum on established TB control activities rather than start a new program with new applicants.
The funding opportunity is identified as CDC RFA PS14-141202CONT16, titled "World Health Organization Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations." The instrument type is a cooperative agreement, which generally means CDC expects to have substantial involvement in the supported work compared to a typical grant. In practical terms, that usually implies ongoing collaboration, technical engagement, and shared planning or oversight between CDC and the awardee to ensure activities align with public health priorities and program objectives.
The activity category is health, and the CFDA listing is 93.116, "Project Grants and Cooperative Agreements for Tuberculosis Control Programs." The opportunity lists an expected number of awards of 50, but the published financial fields show estimated total funding, award ceiling, and award floor all as 0. That kind of entry is common in continuation or administrative notices where the public posting functions more as an official record and mechanism for processing continued support than as a detailed, competitively scored funding announcement with a fixed dollar range for new applicants. There is no cost sharing or matching requirement.
Eligibility is explicitly restricted. Only organizations that were previously awarded under the referenced prior award, "1U52PS004640 CONT 16 Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations - World Health Organization," are eligible to receive continuation funds under this notice. The eligible applicant category is labeled "Others (see text field entitled Additional Information on Eligibility for clarification)," and the clarification makes clear that this is continuation-only funding for prior grantees, effectively limiting eligibility to the existing awardee set rather than the general public.
Key administrative dates show it was posted and created on August 19, 2015, with an original closing date of September 3, 2015, a current closing date of August 25, 2015, and an archive date of October 3, 2015. Those dates matter mainly for recordkeeping and for the continuation processing timeline, since the notice was not designed to solicit new proposals from new organizations.
Programmatically, the purpose is to expand and strengthen strategies that reduce TB transmission, improve prevention and case detection, and enhance treatment outcomes, including for drug-resistant forms of TB that are harder and longer to treat and pose a heightened public health risk. The title also highlights TB in vulnerable populations, which typically includes groups facing elevated exposure risk or barriers to care such as people living in poverty, migrants and displaced persons, incarcerated populations, people living with HIV, and other underserved communities. The framing suggests the continuation supports activities that improve access to quality diagnostics and treatment, strengthen surveillance and program management, and address the specific challenges of MDR-TB and high-risk settings.
For help accessing the full announcement, the notice directs inquiries to the CDC Procurement and Grants Office (PGO) at 770-488-2700 or pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
This is a CDC continuation cooperative agreement intended to support the World Health Organization's ongoing work to prevent and control tuberculosis (TB), with a specific emphasis on multidrug-resistant TB (MDR-TB) and TB in vulnerable populations. It is not described as a new, open competition.
2) What is the opportunity number and title?
The funding opportunity is identified as CDC RFA PS14-141202CONT16. The title is "World Health Organization Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations."
3) Is this an open solicitation for new applicants?
No. The notice is explicitly continuation-only and was issued to continue funding for an existing, previously funded effort rather than to start a new program with new applicants.
4) Who is eligible to apply for this continuation funding?
Eligibility is restricted to organizations that were previously awarded under the referenced prior award: "1U52PS004640 CONT 16 Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations - World Health Organization." No other organizations are listed as eligible in the provided information.
5) What does "Others (see text field...)" mean for eligibility here?
The eligible applicant category is labeled "Others," but the clarification in the eligibility text makes clear this is continuation-only funding for prior grantees under the referenced award. In practice, that limits eligibility to the existing awardee set rather than the general public.
6) What type of funding instrument is used?
The instrument type is a cooperative agreement.
7) What does a cooperative agreement imply for how the work is carried out?
Based on the description provided, a cooperative agreement generally means CDC expects to have substantial involvement in the supported work compared to a typical grant. This can imply ongoing collaboration, technical engagement, and shared planning or oversight between CDC and the awardee to align activities with public health priorities and program objectives.
8) What is the main purpose of the continuation award?
The purpose described is to expand and strengthen strategies that reduce TB transmission, improve prevention and case detection, and enhance treatment outcomes. The emphasis includes drug-resistant TB (including MDR-TB) and TB affecting vulnerable populations.
9) What disease areas and populations are emphasized?
The notice emphasizes TB prevention and control, particularly multidrug-resistant TB (MDR-TB) and TB in vulnerable populations. The information provided indicates a focus on groups facing elevated exposure risk or barriers to care, such as people living in poverty, migrants and displaced persons, incarcerated populations, people living with HIV, and other underserved communities.
10) What kinds of activities does the continuation support (as described in the notice summary)?
The summary indicates activities aimed at improving access to quality diagnostics and treatment, strengthening surveillance and program management, reducing TB transmission, improving prevention and case detection, and enhancing treatment outcomes, including for drug-resistant TB and in high-risk settings.
11) What is the activity category for this opportunity?
The activity category is health.
12) What is the CFDA listing associated with this opportunity?
The CFDA listing is 93.116, "Project Grants and Cooperative Agreements for Tuberculosis Control Programs."
13) Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
14) How many awards are expected?
The opportunity lists an expected number of awards of 50.
15) Why do the estimated total funding, award ceiling, and award floor show as 0?
The published financial fields show estimated total funding, award ceiling, and award floor as 0. The information provided notes that this kind of entry is common in continuation or administrative notices where the public posting functions more as an official record and mechanism for processing continued support than as a detailed, competitively scored funding announcement with a fixed dollar range for new applicants.
16) What are the key administrative dates listed for this notice?
The notice was posted and created on August 19, 2015. It lists an original closing date of September 3, 2015, a current closing date of August 25, 2015, and an archive date of October 3, 2015.
17) Do the listed closing dates affect new applications?
Based on the provided description, the dates are primarily relevant for recordkeeping and the continuation processing timeline, since the notice was not designed to solicit proposals from new organizations.
18) Who should be contacted for help accessing the full announcement?
For help accessing the full announcement, the notice directs inquiries to the CDC Procurement and Grants Office (PGO) at 770-488-2700 or pgotim@cdc.gov.
19) What organization is the continuation intended to support?
The continuation cooperative agreement is focused on supporting the World Health Organization's ongoing work related to TB prevention and control, including MDR-TB and TB in vulnerable populations.
20) What is the referenced prior award tied to eligibility?
The referenced prior award is "1U52PS004640 CONT 16 Expanding Efforts and Strategies to Prevent and Control TB Including Multidrug Resistant TB, and TB in Vulnerable Populations - World Health Organization."
Browse more opportunities from the same category: Health
Next opportunity: Development of a fully functioning hydrographic dataset suitable for the needs of the State of Louisiana by the Department of Environmental Quality
Previous opportunity: Health and Hygiene Activity
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS14 141202CONT16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS14 141202CONT16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R43/R44) Apply for PA 15 335 Funding Number: PA 15 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Imaging Diagnostics of Dental Diseases and Conditions (Caries, Periodontal Disease, Cracked Teeth, and Pulp Vitality) (R41/R42) Apply for PA 15 336 Funding Number: PA 15 336 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Audacious Goal Initiative Discovery based Science to Identify factors Influencing Neural Regeneration in the Visual System (U01) Apply for RFA EY 15 002 Funding Number: RFA EY 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Chemistry, Toxicology, and Addiction Research on Waterpipe Tobacco (R01) Apply for RFA OD 15 005 Funding Number: RFA OD 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Global Health Security Partnership Engagement Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 162101SUPP15 Funding Number: CDC RFA GH15 162101SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Population Based Surveillance of Birth Defects and Data Utilization for Public Health Action Apply for CDC RFA DD16 1601 Funding Number: CDC RFA DD16 1601 Agency: NCBDDD Category: Health Funding Amount: $250,000 |
| NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) Apply for PAR 15 338 Funding Number: PAR 15 338 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Abuse Liability Associated with Reduced Nicotine Content Tobacco Products (R01) Apply for RFA OD 15 006 Funding Number: RFA OD 15 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Rape Prevention and Education Apply for CDC RFA CE14 140103CONT16 Funding Number: CDC RFA CE14 140103CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| AHRQ Health Services Research Projects Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R01) Apply for PA 15 339 Funding Number: PA 15 339 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| High Impact Neuroscience Research Resource Grants (R24) Apply for RFA NS 16 005 Funding Number: RFA NS 16 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sickle Cell Disease in Sub Saharan Africa Data Coordinating Center (U24) Apply for RFA HL 17 007 Funding Number: RFA HL 17 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Sickle Cell Disease in Sub Saharan Africa Collaborative Consortium (U24) Apply for RFA HL 17 006 Funding Number: RFA HL 17 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Multi scale Molecular Profiling of Brains from Psychiatric Cohorts (R01) Apply for RFA MH 16 235 Funding Number: RFA MH 16 235 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Multi scale Molecular Profiling of Brains from Psychiatric Cohorts (Collaborative R01) Apply for RFA MH 16 230 Funding Number: RFA MH 16 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 16 006 Funding Number: HRSA 16 006 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| R40 MCH Research (MCHR) Apply for HRSA 16 032 Funding Number: HRSA 16 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Occupational Safety and Health Education and Research Centers (42) Apply for PAR 15 303 Funding Number: PAR 15 303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| R40 MCH Secondary Data Analysis Studies (SDAS) Apply for HRSA 16 029 Funding Number: HRSA 16 029 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| DELTA FOCUS (Domestic Violence Prevention Enhancement and Leadership Through Alliances, Focusing on Outcomes for Communities United with States) Apply for CDC RFA CE13 130204CONT16 Funding Number: CDC RFA CE13 130204CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS14 141202CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.